Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.86 |
| ▸ | KRAS | P01116 | 6/20 | 0.69 |
| ▸ | NT5E | P21589 | 1/20 | 0.69 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.68 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.64 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.61 |
| ▸ | HINT1 | P49773 | 1/20 | 0.59 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.59 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24409555 | 0.94 | TGM2 (0.83) | TGM2KRASNT5EFUT5DCPS | |
| Phosphoaminophosphonic Acid Guanylate Ester SCHEMBL10334012 | 0.93 | TGM2 (1.00) | TGM2KRASNT5EFUT5DCPS | |
| Phosphoaminophosphonic Acid Guanylate Ester SCHEMBL24591175 | 0.93 | TGM2 (1.00) | TGM2KRASNT5EFUT5DCPS | |
| Phosphoaminophosphonic Acid Guanylate Ester SCHEMBL24409548 | 0.93 | TGM2 (1.00) | TGM2KRASNT5EFUT5DCPS | |
| Phosphoaminophosphonic Acid Guanylate Ester SCHEMBL19278241 | 0.93 | TGM2 (1.00) | TGM2KRASNT5EFUT5DCPS | |
| Phosphoaminophosphonic Acid Guanylate Ester SCHEMBL20680700 | 0.92 | TGM2 (0.98) | TGM2KRASNT5EFUT5DCPS | |
| SCHEMBL21067722 | 0.90 | TGM2 (0.85) | TGM2KRASNT5EFUT5DCPS | |
| SCHEMBL18769114 | 0.90 | TGM2 (0.85) | TGM2KRASNT5EFUT5DCPS | |
| SCHEMBL851357 | 0.90 | TGM2 (0.85) | TGM2KRASNT5EFUT5DCPS | |
| SCHEMBL29429843 | 0.90 | TGM2 (0.85) | TGM2KRASNT5EFUT5DCPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144860-A1 | FLUORESCENT GTP ANALOGUES AND USE | CISBIO BIOASSAYS (FR) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144860-A1 | FLUORESCENT GTP ANALOGUES AND USE | GNAI3, GNAQ, GNB1 | TGM2 140/4885KRAS 9/4885NT5E 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.